查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
细菌性疾病诊断的全球市场（~2033）：按类型、产品、技术和最终用户、区域前景和竞争策略分類的规模和预测
市场调查报告书
商品编码
1351344

细菌性疾病诊断的全球市场（~2033）：按类型、产品、技术和最终用户、区域前景和竞争策略分類的规模和预测

Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 221 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

细菌性疾病诊断市场规模预计将以 6.5% 的年复合成长率成长。

细菌有多种类型。大多数对身体有益，有些具有传染性，病原体是任何可以引起感染疾病的细菌。准确诊断细菌感染对于防止不必要地使用抗生素并提供适当的治疗至关重要。确认细菌感染通常需要多种诊断方法，因为它涉及细菌的存在以及发炎和全身功能障碍。

此外，导致 COVID-19 的新型冠状病毒引发了各国政府对加速实验室检测程序的支持。儘管疫情导致多个行业的收入减少，但 COVID-19 检测的应用帮助了感染疾病诊断市场，并加快了法规机构对 COVID-19 诊断产品的批准。

本报告调查了全球细菌性疾病诊断市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、按类型、产品、区域等详细分析以及竞争形势。的主要企业。

目录

第1章简介

第2章调查方法

第3章执行摘要

第4章市场动态

  • 促进因素、抑制因素、机会与挑战分析
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
  • COVID-19 对全球细菌性疾病诊断市场的影响

第5章市场变数与预测

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 热图分析

第6章竞争形势

  • 製造地、销售区域、产品类型分布
  • 併购、联盟、产品发布、合作

第7章全球细菌性疾病诊断市场：按类型

  • 市场规模份额/预测
  • 细菌性皮肤感染疾病
  • 食物中毒
  • 性行为感染传染病

第8章全球细菌性疾病诊断市场：按产品

  • 市场规模份额/预测
  • 消耗品
  • 装置

第9章全球细菌性疾病诊断市场：依技术分类

  • 市场规模份额/预测
  • DNA微阵列
  • 免疫诊断
  • 恒温核酸增幅技术
  • 聚合酶炼式反应

第10章全球细菌性疾病诊断市场：依最终用户分类

  • 市场规模份额/预测
  • 医院
  • 实验室
  • 研究中心

第11章全球细菌性疾病诊断市场预测

  • 市场规模/市场占有率

第12章全球细菌性疾病诊断市场：按类型

  • 市场规模/市场占有率

第13章全球细菌性疾病诊断市场：按产品

  • 市场规模/市场占有率

第14章全球细菌性疾病诊断市场：依技术分类

  • 市场规模/市场占有率

第15章全球细菌性疾病诊断市场：依最终用户分类

  • 市场规模/市场占有率

第16章全球细菌性疾病诊断市场：按地区

  • 市场规模/市场占有率
  • 亚太地区
  • 欧洲
  • 中东/非洲
  • 北美洲
  • 拉丁美洲

第17章公司简介

  • Abbott Laboratories
  • Accelerate Diagnostics Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Bruker Corp.
  • Danaher Corp
  • DiaSorin SpA
  • EKF Diagnostics Holdings Plc
  • F. Hoffmann La Roche Ltd.
  • GENERI BIOTECH sro
  • Great Basin Scientific
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • Perkin Elmer Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Siemens AG
  • T2 Biosystems Inc.
  • Takara Bio Inc.
  • 其他的

第18章简称表

第19章参考链接

第20章结论

第21章调查范围

简介目录
Product Code: HLCA2357

Introduction and Overview

According to SPER Market Research, 'Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Bacterial Disease Diagnostics Market is predicted to reach with a CAGR of 6.5%.

The several forms of bacteria. However, the majority of them are good for the body while some of them are contagious. Pathogens include all bacteria that are responsible for infectious diseases. To prevent the needless use of antibiotics and to target the right therapy, an accurate diagnosis of bacterial infection is essential. In order to confirm a bacterial infection, more than one diagnostic method is typically needed because it involves the presence of germs as well as inflammation or systemic dysfunction.

Furthermore, the new coronavirus that causes COVID-19 has sparked support from governments all over the world for laboratories to expedite testing procedures. Although the pandemic reduced revenues in several industries, its application in COVID-19 testing helped the market for infectious illness diagnostics. The regulatory authorities hastened the licencing of COVID-19 diagnostic products.

Scope of the Report

Report Metric Details:

  • Market size available for years: 2019-2033
  • Base year considered: 2022
  • Forecast period: 2023-2033
  • Segments covered: By Type, By Product, By Technology, By End User
  • Regions covered: North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
  • Companies Covered: Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., Meridian Bioscience Inc., Perkin Elmer Inc., Quest Diagnostics Inc., and Takara Bio Inc., Others

Market Segmentation:

  • By Type: Based on the Type, Global Bacterial Disease Diagnostics Market is segmented as; Bacterial Skin Infections, Foodborne Infections, Sexually Transmitted Infections.
  • By Product: Based on the Product, Global Bacterial Disease Diagnostics Market is segmented as; Consumables, Instruments.
  • By End User: Based on the End User, Global Bacterial Disease Diagnostics Market is segmented as; Hospitals, Labs, Research Centres.
  • By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Bacterial Disease Diagnostics Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Bacterial Disease Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bacterial Disease Diagnostics Market

7. Global Bacterial Disease Diagnostics Market, By Type (USD Million)

  • 7.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Type, 2023-2033
  • 7.2. Bacterial Skin Infections
  • 7.3. Foodborne Infections
  • 7.4. Sexually Transmitted Infections

8. Global Bacterial Disease Diagnostics Market, By Product (USD Million)

  • 8.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Product, 2023-2033
  • 8.2. Consumables
  • 8.3. Instruments

9. Global Bacterial Disease Diagnostics Market, By Technology (USD Million)

  • 9.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Technology, 2023-2033
  • 9.2. DNA Microarray
  • 9.3. Immunodiagnostics
  • 9.4. Isothermal Nucleic Acid Amplification Technology
  • 9.5. Polymerase Chain Reaction

10. Global Bacterial Disease Diagnostics Market, By End User (USD Million)

  • 10.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By End User, 2023-2033
  • 10.2. Hospitals
  • 10.3. Labs
  • 10.4. Research Centres

11. Global Bacterial Disease Diagnostics Market Forecast, 2019-2033 (USD Million)

  • 11.1. Global Bacterial Disease Diagnostics Market Size and Market Share

12. Global Bacterial Disease Diagnostics Market, By Type, 2019-2033 (USD Million)

  • 12.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2019-2026)
  • 12.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2027-2033)

13. Global Bacterial Disease Diagnostics Market, By Product, 2019-2033 (USD Million)

  • 13.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2019-2026)
  • 13.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2027-2033)

14. Global Bacterial Disease Diagnostics Market, By Technology, 2019-2033 (USD Million)

  • 14.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2019-2026)
  • 14.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2027-2033)

15. Global Bacterial Disease Diagnostics Market, By End User, 2019-2033 (USD Million)

  • 15.1. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2019-2026)
  • 15.2. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2027-2033)

16. Global Bacterial Disease Diagnostics Market, By Region, 2019-2033 (USD Million)

  • 16.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2019-2026)
  • 16.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. Abbott Laboratories
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Accelerate Diagnostics Inc.
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Becton Dickinson and Co.
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. Bio Rad Laboratories Inc.
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. bioMerieux SA
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. Bruker Corp.
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. Danaher Corp
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. DiaSorin SpA
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. EKF Diagnostics Holdings Plc
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. F. Hoffmann La Roche Ltd.
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. GENERI BIOTECH s.r.o.
    • 17.11.1. Company details
    • 17.11.2. Financial outlook
    • 17.11.3. Product summary
    • 17.11.4. Recent developments
  • 17.12. Great Basin Scientific
    • 17.12.1. Company details
    • 17.12.2. Financial outlook
    • 17.12.3. Product summary
    • 17.12.4. Recent developments
  • 17.13. Hologic Inc.
    • 17.13.1. Company details
    • 17.13.2. Financial outlook
    • 17.13.3. Product summary
    • 17.13.4. Recent developments
  • 17.14. Meridian Bioscience Inc.
    • 17.14.1. Company details
    • 17.14.2. Financial outlook
    • 17.14.3. Product summary
    • 17.14.4. Recent developments
  • 17.15. Perkin Elmer Inc.
    • 17.15.1. Company details
    • 17.15.2. Financial outlook
    • 17.15.3. Product summary
    • 17.15.4. Recent developments
  • 17.16. QIAGEN NV
    • 17.16.1. Company details
    • 17.16.2. Financial outlook
    • 17.16.3. Product summary
    • 17.16.4. Recent developments
  • 17.17. Quest Diagnostics Inc.
    • 17.17.1. Company details
    • 17.17.2. Financial outlook
    • 17.17.3. Product summary
    • 17.17.4. Recent developments
  • 17.18. Siemens AG
    • 17.18.1. Company details
    • 17.18.2. Financial outlook
    • 17.18.3. Product summary
    • 17.18.4. Recent developments
  • 17.19. T2 Biosystems Inc.
    • 17.19.1. Company details
    • 17.19.2. Financial outlook
    • 17.19.3. Product summary
    • 17.19.4. Recent developments
  • 17.20. Takara Bio Inc.
    • 17.20.1. Company details
    • 17.20.2. Financial outlook
    • 17.20.3. Product summary
    • 17.20.4. Recent developments
  • 17.21. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope